Improving subjective perception of personal cancer risk: systematic review and meta-analysis of educational interventions for people with cancer or at high risk of cancer by Dieng, Mbathio et al.
1 
 
Improving subjective perception of personal cancer risk: systematic review and meta-analysis 
of educational interventions for people with cancer or at high risk of cancer 
Mbathio Dieng
1
, Caroline G Watts
1
, Nadine A Kasparian
2
, Rachael L Morton
3
, Graham J Mann
4
, 
Anne E Cust
1
. 
 
1) Cancer Epidemiology and Services Research, Sydney School of Public Health, The 
University of Sydney,  NSW 2006, Australia. 
 
2) School of Women’s and Children’s Health, UNSW Medicine, University of New South 
Wales, NSW 2031, Australia. 
 
3)  Sydney School of Public Health, The University of Sydney, NSW 2006, Australia. 
 
4) Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium 
Institute and Melanoma Institute Australia, NSW 2145, Australia 
 
Short title: The effect of psycho-educational interventions on cancer risk perception. 
 
Please address correspondence to: Mbathio Dieng, Cancer Epidemiology and Services Research, 
Building D02, Sydney School of Public Health, The University of Sydney, NSW, 2006 Australia. 
Tel: +61 293514902 
mbathio.dieng@sydney.edu.au 
 
 
 
  
2 
 
ABSTRACT 
Objective: To assess the effectiveness of educational interventions in improving subjective cancer 
risk perception, and to appraise the quality of the studies.  
Method: We conducted a systematic review and meta-analysis of randomised controlled trials and 
prospective observational studies. Eligible studies were identified via Medline, PsycINFO, AMED, 
CINAHL and Embase databases. After screening titles and abstracts, two reviewers independently 
assessed the eligibility of 206 full-text articles. 
Results: 40 papers were included in the review; the majority of studies were conducted among 
breast cancer patients (n=29) and evaluated the effect of genetic counselling on personal perceived 
risk (n=25). Pooled results from randomised controlled trials (n=12) showed that, both in the short 
and long term, educational interventions did not influence level (standardised mean difference 0.05, 
95% CI -0.24 to 0.34; p=0.74) or accuracy (odds ratio for improved risk accuracy =1.96, 95% CI: 
0.61 to 6.25; p=0.26) of risk perception. Only one randomised controlled trial reported a short term 
difference in risk ratings (p=0.01). Of prospective observational studies (n=28), many did 
demonstrate changes in level of perceived risk, and improved risk accuracy and risk ratings in both 
the short and long term. However, only one (of 3) observational studies reported a short term 
difference in risk ratings (p<=0.003).  
Conclusion: Despite favourable results from prospective studies, there was no clear evidence from 
randomised controlled trials to support the effectiveness of educational interventions in improving 
cancer risk perception. Further development and investigation of educational interventions using 
good quality, randomised controlled trials is warranted.  
Systematic review registration: PROSPERO register (Registration number: CRD42012002861) 
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INTRODUCTION 
People newly diagnosed with cancer require education about the disease, available treatments and 
the potential consequences of treatment. A review by Mills and Sullivan
1 
found that effective cancer 
education increased patients’ control and involvement in their care, reduced psychological distress, 
and improved adherence to treatment. Although the ultimate goal of health education interventions 
is to positively influence health status, the indicators of success are often changes in intermediate 
outcomes, such as subjective perception of personal risk (“risk perception”), which are critical to 
the longer-term outcomes of cancer prevention and control. Perception of cancer risk has been 
found to be theoretically and empirically relevant in motivating cancer screening and risk reduction 
behaviours.
2-4
 Research by Kreuter
5 6
 concluded that people who underestimate their risk of 
developing cancer may be less likely to engage in health-protective behaviours, whereas those who 
overestimate their risk may worry excessively, overdo protective behaviours, and burden the health 
care system. Cancer risk perception is associated with health-related quality of life, including 
psychological adjustment, and health behaviours.
7 For example, Waters et al
8
 found that high 
perceived cancer risk was associated with lower mental and physical health-related quality of life. 
Kinsinger et al
9
 observed that perceived risk of breast cancer was positively associated with 
depression, anxiety, and worry about cancer.  
 
Despite the established importance of risk perception and the increasing number of educational 
interventions targeting risk perception for both cancer patients and people at risk of cancer, there is 
little research investigating the efficacy of these interventions. In 2006, a systematic review by 
Braithwaite and colleagues
10
 examined the impact of genetic counselling for breast, ovarian, and 
colorectal cancer on a range of cognitive, affective, and behavioural outcomes. Based on evidence 
from controlled trials, the review concluded that genetic counselling does not influence risk 
4 
 
perception; however, other evidence from prospective studies did suggest an increase in the 
accuracy of perceived risk over time. More recently, Albada et al. conducted a review specifically 
focused on the effects of tailored information about cancer risk, and screening interventions.
11
 This 
review found that compared to standard information, tailored information using behavioural 
constructs and risk factors improved level of cancer risk perception. 
 
No reviews have investigated the impact of all types of educational interventions on cancer risk 
perception. The aim of this systematic review and meta-analysis was to 1) assess the effectiveness 
of educational interventions on subjective cancer risk perception in the short and long-term, across 
all types of interventions and cancers, and 2) critically appraise the quality of the included studies. 
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METHODS 
The protocol for this review was registered in the PROSPERO register (Registration number: 
CRD42012002861) http://www.crd.york.ac.uk/PROSPERO in August 2012. The Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines
12
 were 
followed to identify and screen publications, extract data and describe the systematic review 
protocol. 
 
Inclusion criteria 
Studies published in a peer-reviewed journal and that met all of the following criteria were included 
in the review: 
 The study evaluated the impact of an educational intervention on cancer risk perception; 
 The intervention was an educational intervention of any form including genetic counselling; 
 The study assessed and reported personal cancer risk perception as a primary or secondary 
outcome; 
 The intervention targeted people affected by cancer (cancer patients, cancer survivors), 
people who were at high or moderate risk of developing cancer, or who were referred to 
genetic counselling because of a personal or family history of cancer. 
 
Exclusion criteria 
We excluded studies that: 
 involved only caregivers; 
 were conducted only among the general population (i.e. not targeted at risk groups); 
 were case studies, conference abstracts, systematic reviews or meta-analyses.  
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Search strategy  
 In January 2013, we searched international electronic bibliographic databases Medline (1950 to 
January 2013), PsycINFO (1806 to January 2013), Allied and Complementary Medicine (AMED) 
(1985 to January 2013), Cumulative Index to Nursing and Allied Health Literature (CINAHL) 
(1982 to January 2013) and Embase (1966 to January 2013). We also conducted hand-searches of 
the reference lists of included papers. With the exception of human research, the search was 
conducted without limitations by country, language or year. Our search strategy was developed in 
Medline and adapted to other databases (see supplementary table 1). In addition, in order to 
examine how well melanoma was captured under the broader term of “neoplasm”, we conducted a 
complementary search using “melanoma” as a MeSH term and text word. This was done to 
facilitate future work in our broader melanoma research programme. 
 
Study selection 
Study selection was conducted in two distinct rounds. In the first round, one reviewer (MD) 
screened all titles and abstracts for non-research articles, duplicates and ineligible publications such 
as single case reports, letters, commentaries, conference abstracts, or those focused on other topics. 
Non-English abstracts were translated using Google Translator (http://translate.google.com.au/). In 
the second round, the full text of all remaining papers was examined independently by two 
reviewers (MD and CW). When there was disagreement, two external reviewers (NK and AC) were 
consulted and inclusion was agreed by consensus. The reference lists of all publications identified 
were examined for other potentially relevant papers not captured by the initial search strategy. 
Data were extracted using a predefined data form developed using the PICOS (participants, 
interventions, comparators, outcomes, and study design) approach.
12
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Appraisal and quality assessment 
A specific quality appraisal tool was used for each type of study design (prospective observational 
or randomised controlled trial (RCT)). Methodological quality was assessed independently by two 
reviewers (MD and CW). For RCTs, we used the Cochrane collaboration tool for assessing risk of 
bias.
13
 It is a domain-based evaluation which is used to critically assess six domains of bias: 
selection bias, performance bias, detection bias, attrition bias, reporting bias, and other bias.
13 
For 
assessing the quality of prospective observational studies, we used the Quality Assessment Tool for 
Quantitative Studies,
14
  which has been judged to be suitable to use for systematic reviews of 
effectiveness.
15
 This tool includes 21 items separated into eight components: selection bias, study 
design, confounders, blinding, data collection methods, withdrawals and dropouts, intervention 
integrity and analysis.  
 
Analysis of the effectiveness of the educational interventions 
Synthesising the results of all the included studies was challenging because of the heterogeneity of 
study designs, populations, interventions and outcomes in the included studies. We synthesised the 
evidence according to how risk perception was reported in each paper (mean perceived risk, risk 
accuracy, risk rating), as it was assessed using different scales and presented in different ways 
across studies. We presented results separately for RCTs and prospective observational studies. 
Results for both study types were presented as forest plots where possible; however a formal meta-
analysis of results (i.e. to show a pooled effect) was performed only for RCTs due to the 
heterogeneous prospective observational study designs. We used Cochrane software RevMan5
16
 to 
summarise the estimates of effect and to produce figures.  
 
 
 
 
8 
 
RESULTS 
Literature search 
We identified 3386 papers through database searching and 13 additional papers were located 
through manual searching (Supplementary figure 1). These were reduced to 206 potentially eligible 
studies after removing duplicates and applying the inclusion and exclusion criteria to the titles and 
abstracts. After assessment of the full text of the remaining papers, 40 studies that examined the 
effect of educational interventions on cancer risk perception among people affected by cancer, or 
at moderate or high risk of cancer, or were referred to genetic counselling because of a 
personal or family history of cancer, were included in the review. Of these, 12 were RCTs and 
28 were prospective observational studies, conducted in the United States (n=11), United Kingdom 
(n=13), Sweden (n=4), Australia (n=3), Canada (n=3), The Netherlands (n=2), Norway (n=1), Spain 
(n=1), Israel (n=1), and Denmark (n=1).  
 
Characteristics of included studies 
Randomised Controlled Trials (n=12) 
Ten RCTs were conducted among breast cancer patients and two among melanoma patients (Table 
1). Sample sizes ranged from 40 to 545 participants, and the mean number of participants was 248. 
Of the ten breast cancer RCTs, four tested the effect of genetic counselling or genetic risk 
assessment,
17-20
 one tested the effect of a pre-visit (breast cancer genetic counselling visit) 
educational website versus usual care,
21
 one measured the effect of an alternative model of cancer 
genetics consultation by genetic nurse specialists versus standard service,
22
 one evaluated the effect 
of a computer-based programme followed by genetic counselling versus standard one-on-one 
genetic counselling,
23
 one evaluated the impact of a psychoeducational information pack 
versus scientific information pack versus standard care only,
24
 one evaluated the effect of a 
psycho-educational group intervention
25 
and one tested the effect of genetic counselling plus nurse 
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consultation versus standard genetic counselling.
26
 Of the two interventions in melanoma education, 
one evaluated an intervention with interactive education, education brochure and 
telecommunication reminders to perform skin self-examination versus usual care
27
 and one 
evaluated the effect of a multimedia health education programme (Skinsafe).
28
  
 
Prospective observational studies (n=28) 
Of the 28 prospective observational studies, 25 used a standard “pre and post” design29-54 whereby 
all individuals were assessed before and after participation in the intervention, and three studies
43 55 
56
 
 
used a different “pre and post” design whereby two groups were given the intervention at 
different times and the two groups were compared at the completion of the study. The majority 
(n=18) of the observational studies were conducted among breast cancer patients, two among 
colorectal cancer patients, one with ovarian cancer patients, one among pancreatic cancer patients 
and six with familial cancer patients (Table 1). Sample sizes ranged from 34 to 517 participants, and 
the mean number of participants was 152. Most (n=19) evaluated the effect of genetic counselling 
on personal perceived risk,
29 32 33 35-38 40 42-45 47-50 52 53 55
 three evaluated the effectiveness of cancer 
education sessions,
39 51 54
 one involved a cancer risk evaluation programme,
34
 one was an 
educational support group,
46
 one was a cancer genetics consultation,
31
 one was an educational video 
intervention,
56
 one was a cancer counselling and screening programme,
30
 and one was an 
information aid.
41
  
 
Risk perception measures 
A range of self-reported measures of perceived risk were used across studies, including categorical 
and continuous variables, and both absolute and comparative risk estimates. Perceived risk was 
measured using scales of various length, ranging from 1 to 5 items; 17 studies (41%)
17 21 22 24 28 30 31 
34 36 43 45 47 50-53 56
 used a single-item measure of risk perception, eight used a two-item measure,
18 19 
10 
 
26 32 39 40 49 54
 six used a three-item measure,
23 33 35 37 46 48
 two used a four-item measure,
20 42
 two 
studies used a five-item measure,
29 55
 and five studies did not describe the measure used to assess 
risk perception.
25 27 38 41 44
  
 
Impact of cancer educational interventions on risk perception 
Level of perceived risk  
Six RCTs reported the impact of educational interventions on the level of risk perception; four of 
these were able to be summarised as the standardised mean difference between treatment group 
means, standardised by the standard deviation at follow-up pooled across treatment groups (Figure 
1). Three of the studies reported short-term (<=3 months) effects. The pooled result indicated no 
short-term effect of these interventions (standardised mean difference 0.05 (95% CI -0.24, 0.34); 
p=0.74). Two trials reported long-term effects (>3 months); one after 6 months follow-up
20
 and one 
after 9 months follow-up
18
 (Figure 1). The pooled long-term effect was small (standardised mean 
difference -0.37; (95% CI -0.98, 0.24) and not statistically significant (p=0.23). There was 
significant heterogeneity of effect sizes between studies (χ2= 25.73; df = 4; N=5; p<0.0001); 
however, it was difficult to explore sources of heterogeneity due to the small total sample. 
 
Two RCTs
23 25 that measured mean level of risk perception were not included in Figure 1; the study 
by Green and colleagues
23 
did not report a standard deviation, and the study by Kash et al.
25
 
reported a risk perception score range. Green’s study23 found high risk participants’ perception of 
risk of developing breast cancer decreased significantly from 62 to 56 (on a scale of 0-100) 
(p=0.006) after either counselling or computer programme use.  Kash’s study25 also concluded that 
the psycho-educational intervention significantly reduced perceived risk (mean perceived score 
decreased from 51% - 60% at baseline to 21% - 30% at 6 weeks, 6 months and 1 year; p<0.01), 
which had been highly overestimated by women prior to intervention use. One study by Appleton 
11 
 
et al.
24
 was not clear about how they summarise risk perception so we could not include it in 
figure 1. Appleton study found that people who received the scientific information only 
experienced a significant decrease in perceived likelihood of developing breast cancer 
(p=0.039).  
 
Figure 2 summarises the impact of the interventions on mean level of risk perception from eight 
prospective observational studies. Of 7 studies assessing short-term outcomes, three reported a 
statistically significant change from baseline level of mean perceived risk
34 35 48
 and four studies
30 40 
47 52
 reported no statistically significant change. Over the longer term, one study reported a 
statistically significant change from baseline level of mean perceived risk,
39
 and two studies
40 47
 
reported no change. 
Another three studies
29 42 44
 did not report standard deviations and thus could not be presented in 
Figure 2; however, each of these studies showed improvements in perceived risk after genetic 
counselling. Mertens and colleague’s 44 found that patient 5-year risk perceptions decreased 
significantly (-11.5%; p<0.0001) but remained significantly higher than the objective estimates 
(mean difference 18.7%; p<0.0001). Rantala and colleague’s study29 reported a statistically 
significant decrease in perceived risk reported by unaffected subjects after genetic counselling 
(p<0.001). Sagi et al.
42
 also found a significant decrease in perceived risk after genetic counselling 
(t =2.2, df=45, p≤ 0.05).  
 
Risk accuracy 
Risk accuracy was described as the level of concordance between perceived risk estimates and 
calculated or counselled risk estimates (objective risk). However, different epidemiological models 
of risk and definitions of accuracy were used across studies.  
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Two RCTs
17 26
 assessed the association between educational interventions and risk accuracy (Figure 
3). The pooled results show that in the short-term, there was no difference in risk accuracy for the 
intervention versus comparison group (odds ratio (OR) for improved risk accuracy =1.96; 95% CI: 
0.61, 6.25; p=0.26). Only one randomised trial
26
 reported the long-term (8 month) effect of the 
intervention and found no difference (OR=1.14; 95% CI: 0.53, 2.46; p= 0.73).  
 
Improvements in accuracy of risk perception were observed in 8 of 10 observational studies that 
evaluated short-term effectiveness (Figure 4), and most of these demonstrated strong effects; for 
example, four studies
32 33 36 38
 had an OR > 4 for improved risk accuracy. In the long-term, four 
studies
33 37 43 55
 reported significant improvements in risk accuracy after educational intervention 
(Figure 4). 
 
One prospective cohort study by Alexander et al.
54
 reported subjective and objective perceived risk 
as median risk estimates. This study found that initially, women substantially overestimated their 
chance of getting breast cancer; however, after an educational intervention, perceived risk shifted 
closer to the calculated objective risk although remained significantly higher (p<0.0001). 
 
Risk rating 
Six studies (three RCTs
22 27 28
 and three observational
41 49 51
) reported the proportion of participants 
who believed their risk to be moderate or high compared to the proportion whose objective risk was 
moderate or high (Supplementary table 2). Most of these studies demonstrated that at baseline, the 
majority of participants overestimated their risk as moderate or high compared to their objectively 
calculated risk. In the short term, one RCT
22
 and one observational study
41
 
 
reported a statistically 
significant difference in risk ratings (p=0.01; and p <=0.003 respectively). Two other studies
28 49 
did 
not report objective risk to compare with participants’ subjective risk. 
13 
 
 
Predictors of change in perceived risk 
Two RCTs and eight observational studies used multiple regression to identify the predictors of 
improvement in risk perception; Supplementary table 3 shows the statistically significant predictors 
that were identified. Covariates found to be associated with a change in perceived risk included 
baseline risk perception, age, ethnicity, and cancer-related worry, among several others. One RCT
21
 
and one observational study
45
, not presented in the table, found that none of the tested covariates 
(age, baseline genetic knowledge, educational level) were significantly associated with change. 
Baseline perceived risk was the most strongly and consistently reported factor associated with post 
intervention risk perceptions across studies. 
 
Quality assessment 
The quality assessment of included RCTs was summarised in supplementary figure 2. For items 
related to potential risk of bias due to allocation, nine
17 18 20-24 27 28
 of 12 RCTs provided a 
description indicating that the sequence was adequately generated and that the allocation was 
adequately concealed, and three studies
19 25 26
 had unclear descriptions of these processes. Blinding 
of participants, personnel and outcome assessors was reported as present in five studies,
17-19 25 26
 not 
adequately described in three,
20 22 23
 and four explicitly described their study was not blinded.
21 24 27 
28
 Incomplete outcome data were adequately described in two studies,
21 24
 unclearly described in 
nine studies
17 19 20 22 23 25-28
 and not adequately described to judge risk of bias in one study.
18
 For 
potential risk of bias from selective reporting, only one study
21
 indicated that a protocol was 
available by providing the trial registration number. Two studies
21 23
 did not indicate any other 
potential threats to validity, two
26 27
 did not provide an adequate description to judge potential risk 
of bias on this item, and eight
17-20 22 24 25 28
 discussed other potential risks of bias.  
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The quality assessment of prospective observational studies across eight domains was summarised 
in Supplementary figure 3.  Overall, 75% of these studies were of moderate quality and 25% of 
weak quality; we found no studies of strong quality. “Selection bias” was the domain in which the 
studies performed best, and “data collection” was the worst performing domain. More than 70% of 
the studies used risk perception measures that were not validated. 
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DISCUSSION 
Cancer risk perception is related to quality of life and health behaviours,
7
 and the use of educational 
tools aimed at improving risk perception is becoming more common. The results from this review 
show that there is no clear evidence to support the effectiveness of educational interventions to 
improve subjective perception of cancer risk. Despite favourable results from prospective studies, 
pooled results from RCTs showed that, both in the short and long term, educational interventions 
did not have a statistically significant impact on level, accuracy or rating of perceived risk 
perception. The majority of included studies were of moderate quality and selection bias was the 
domain where most studies (both RCTs and observational studies) performed best. 
 
This review is the first, to our knowledge, to summarise the impact of educational interventions for 
people with cancer or those at high or moderate risk of cancer, across all types of educational 
interventions and cancers. Most previously published reviews looked at only one type of 
educational intervention
10 11 57-59 
such as genetic counselling or focused on one type of cancer.
60
 One 
strength of our review was the inclusion of all study designs, as both RCTs and observational 
studies provided a different perspective.  The diversity of educational interventions and risk 
perception summary measures from the included studies means that some caution is needed in the 
interpretation of the pooled data. To address this issue, we classified risk perception using three end 
points (level of risk perception, risk accuracy and risk rating) and we also separated short and long 
term effects where appropriate. However, our pooled RCT results consistently showed that cancer 
educational interventions do not have a statistically significant impact on perceived risk.  
 
Our review also has several limitations. First, a search of the grey literature, particularly conference 
abstracts and unpublished theses, was not conducted, so publication bias could not be completely 
eliminated. Second, there was an overrepresentation of patients with breast cancer and therefore of 
16 
 
women. The generalisability of results to other types of cancer and to men is unclear. Third, in our 
quality assessment, we relied on information about methodology as reported in the articles. For 
observational studies, information about confounding and blinding was often missing; we then 
scored these studies as “moderate” methodological quality without contacting authors for 
verification. Fourth, some RCTs in our review could not be pooled with results from other studies 
because of missing data or different measures. Omission of these studies may have influenced the 
overall pooled results and thus the conclusions of the review. To provide more information about 
these individual studies, we included brief details on their findings in our manuscript text. Finally, 
when examining risk accuracy, different methods for defining, measuring and analysing the data 
were used across studies, influencing our ability to compare changes from baseline. 
 
Unlike the RCTs, many of the prospective observational studies included in this review 
demonstrated statistically significant improvements in the level, accuracy and rating of perceived 
risk. It is unclear why there was a discrepancy between the results of RCTs and observational 
studies. Compared to RCTs, observational studies are considered more prone to bias, such as 
confounding and publication bias,
61
 so we cannot exclude the possibility that bias influenced the 
observed effects in the observational studies. However, two studies published in The New England 
Journal of Medicine in 2000 found that observational studies and RCTs overall produced similar 
results.
62 63
 The authors of these findings cast doubt on the ideas that "observational studies should 
not be used for defining evidence-based medical care" and that RCT' results are "evidence of the 
highest grade." 
62 63
 A 2001 study published in the Journal of the American Medical Association 
concluded that "discrepancies beyond chance do occur and differences in estimated magnitude of 
treatment effect are very common" between observational studies and RCTs.
64
 Another possible 
explanation could be that the types of interventions differed somewhat across the two study designs; 
as a higher proportion of the observational studies (68%) used genetic counselling interventions, 
17 
 
compared to 36% of RCTs. Previous systematic reviews and meta-analyses have shown that genetic 
counselling may be effective in improving risk perception,
59 
particularly for breast cancer risk.
57 58
 
However, a systematic review by Braithwaite et al.
10
 found that although genetic counselling 
improved knowledge of cancer genetics it did not alter the level of perceived risk. Similar to our 
study results, they found evidence of effectiveness from observational studies but not from RCTs.
10  
 
Perception of cancer risk has been reported to be relatively resistant to change over time.
65 66  This 
could be explained by two factors: first, people often find information on health risks difficult to 
understand.
67 68
 According to the UK National Cancer Institute,
69
 people do not always have a clear 
understanding of the risks of cancer, or of the likelihood of various outcomes of cancer screening 
tests and treatments. This could be due to the complexity that is often inherent in information about 
risk, as well as the need for adequate numeracy and literacy skills to understand the information. 
Second, communication of risk information to consumers requires clear presentation and wording, 
however, there is no consensus as to which format is most effective in terms of facilitating patient 
understanding of risk information.
67  
 
In this review there was an array of educational intervention formats ranging from standard 
genetic counselling to information aids.  The majority of interventions focused on genetic 
counselling with an informational approach delivered by genetic counsellors, clinical 
geneticists, nurses or surgeons. A few studies used a combination of educational components 
and psychological support, or were solely psychological in nature (as outlined in Table 1). 
Furthermore, few studies had a well-articulated, theoretical basis on which the intervention 
was designed; only three studies
25 46 49
 relied on the cognitive restructuring, emotional 
support, coping, and common sense model.  It is likely that the differences in the format and 
design of the interventions contributed to the variation in our review results. Further studies 
18 
 
should ideally base their intervention on a psychological framework, as this may be useful in 
understanding the way people form personal perceived risk beliefs.   
 
Many studies in this review used single-item measures of risk perception. This is consistent with the 
findings of a recent review by Tilbert et al.
70
 which discussed the one dimensional character of risk 
perception measures (i.e. measuring magnitude or frequency of risk, but not both).  In this review, it 
is not known to what extent some of the heterogeneity or non-significant results are related to the 
measure used to assess perceived risk. However, it is clear that standardising and validating multi-
dimensional perceived risk measures would be of benefit to the field, particularly when comparing 
outcomes across studies.  
 
Cancer patients or people at moderate or high risk of cancer often overestimate their risk of 
developing cancer. While acknowledging that there is still uncertainty about the accuracy of 
objective cancer risk estimates, there is evidence that improving cancer risk perception has 
several health benefits. Previous research by Hopwood concluded that an understanding of a 
person’s risk perception, which is grounded in knowledge of his true risk, is necessary for risk 
management and decision making.
71
 Evaluating risk accuracy is also important in the sense 
that it can encourage more appropriate health care behaviours, as people who overestimate 
their risk may perform excessive preventive strategies whilst under-estimators may have poor 
preventive health behaviours. In addition, risk information can be useful for the clinician to 
facilitate discussions regarding risk management, screening and prevention.
72 73
 
Analyses of predictors of change in risk perception indicated that several variables such as baseline 
risk perception, age, ethnicity, and cancer-related worry were associated with changes in risk 
perception. Our findings are similar to a review of perceived risk and breast cancer screening,
74
 
which found weak but statistically significant associations between perceived risk and age, ethnicity 
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and breast cancer worry. Information about which factors predict changes in perceived risk could 
help clinicians and researchers tailor the design of interventions that are relevant to and appropriate 
for particular groups. 
Although this review was based on a limited number of studies with a wide range of interventions, 
based on our results we would not recommend broad use in clinical practice of educational 
interventions to improve cancer risk perception. Despite favourable results from prospective 
studies, there was no clear evidence from RCTs to support their effectiveness. 
Many challenges remain in improving cancer risk perception. Our review shows that measurement 
of perceived risk is often one-dimensional, non-standardised and reliant on the use of non-validated 
measures. Further research should focus on the development of new measures for cancer risk 
perception and test whether a multidimensional measure, combining different elements of risk 
perception, is feasible and adequate. Risk accuracy appears more amenable to change than mean 
perceived risk or risk rating, but this also needs further investigation. As demographic 
characteristics and psychosocial factors influence changes in perceived risk, future studies should 
integrate these factors into the design and implementation of educational interventions. Most of the 
published literature has focused on breast cancer, so studies in other cancers and particularly among 
men and people of diverse socioeconomic and cultural groups would help to assess the 
generalisability of findings. Finally, given the promising results from many observational studies 
with “pre and post” study designs, further investigation of well-designed educational interventions 
using good quality, randomised controlled trials is warranted. These future research directions will 
help to clarify the effectiveness of educational interventions for improving cancer risk perception. 
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Table 1: Characteristics of included studies 
Reference Country/Region Type of cancer Type of intervention Participants 
N 
(Baseline) 
Randomised Controlled trials 
Albada 2012
21 
Netherlands Breast  
Pre-visit educational website (E-info gene) vs. usual 
care (brief standard pre-visit leaflet). 
Women attending a genetic counselling 
clinic for breast cancer. 
 197 
Appleton
24
 United Kingdom Breast 
Psychoeducational (scientific and pschosocial 
information) written information pack vs. 
Scientific information pack vs. standard care 
only. 
Women attending the Ardmillan 
Familial Breast Cancer Clinic 
163 
Aneja 2012
27 
United States Melanoma 
Intervention with interactive education and 
telecommunication reminders vs. usual care 
Participants from dermatology clinics 
with low or high risk of melanoma. 
210 
Bowen 2004
20 
United States Breast  
Individual genetic counselling vs. group 
psychosocial counselling vs. delayed intervention. 
Participants were recruited from among 
family members of women with breast 
cancer. 
348 
Brain 2000
18 
United Kingdom Breast 
Multidisciplinary genetic assessment vs. surgical 
assessment. 
Women residing in Wales from two 
family cancer clinics. 
545 
Braithwaite 2005
19 
United Kingdom Breast  
GRACE (genetic risk assessment in the clinical 
environment) tool vs. genetic risk counselling. 
Women with a family history of breast 
cancer. 
72 
Fry 2003
22 
United Kingdom Breast  
Novel community-based service vs. standard 
regional service. 
Women referred to the regional clinical 
genetics department for breast cancer 
genetic risk counselling. 
373 
Glazebrook 2006
28 
United Kingdom Melanoma 
Multimedia health education programme (Skinsafe) 
vs. control. 
Patients at high risk of developing 
melanoma and attending family 
practices within Nottinghamshire. 
459 
Green 2004
23 
United States Breast  
Computer based programme followed by genetic 
counselling vs. standard one-on-one genetic 
counselling. 
Women with personal or family 
histories of breast cancer recruited from 
outpatient clinics. 
211 
Kash 1995
25 
United States Breast Psycho-educational group intervention vs. control Women at high risk of breast cancer. 40 
Lerman 1995
17 
United States Breast 
Breast cancer risk counselling vs. general health 
counselling. 
Women with family history of breast 
cancer identified by a relative who was 
200 
25 
 
under treatment for breast cancer at a 
comprehensive cancer centre. 
Roshanai 2009
26 
Sweden Breast 
Standard genetic counselling + nurse consultation 
vs. standard genetic counselling alone. 
Women attending the cancer genetic 
clinic of Uppsala University Hospital 
163 
 Observational studies 
Alexander 1995
54 
United States Breast  
90 minute breast cancer educational session with 
general internist 
Women at high risk of breast cancer 
who participated in the Tamoxifen 
Breast Cancer prevention trial. 
59 
Bish 2002
40 
United Kingdom Breast/ovarian Genetic counselling 
Women who have been treated for 
breast or ovarian cancer and unaffected 
women referred to the Department of 
Clinical Genetics for genetic 
counselling. 
181 
Bjorvatn 2007
35 
Norway Breast/ovarian Genetic counselling 
People receiving counselling for cancer 
risk at the genetic outpatient clinics of 
in three university hospitals in Norway. 
213 
Cabrera 2010
53 
Spain Breast  Genetic counselling 
Participants with familial history of 
breast cancer who were referred for 
genetic counselling at a hospital in 
Barcelona. 
212 
Codori 2005
52 
United States Colorectal Genetic counselling 
Adults at increased risk of HNPCC due 
to a family history of colorectal cancer. 
101 
Collins 2000
51 
Australia Colorectal 
1 hour session at a family cancer clinic + follow up 
letters outlining the issues discussed in the session 
Individuals referred to a family cancer 
clinic by their GPs, family members or 
self referred. 
126 
Cull 1998
56 
United Kingdom Breast  Educational video before clinic consultation 
Women newly referred to a breast 
cancer family clinic. 
128 
Evans 1994
55 
United Kingdom Breast  Genetic counselling +population risk information 
Women who were referred to a genetic 
clinic for counselling. 
517 
Gagnon 1996
39 
Canada Breast 
Special surveillance breast programme (20 minute 
session with a breast surgeon) 
Women who made an appointment at 
the Memorial Sloan Kettering cancer 
Centre special surveillance breast 
94 
26 
 
programme (a programme for women at 
high risk of breast cancer). 
Gurmankin 2005
34 
United States Breast 
Cancer risk evaluation programme including 
genetic counselling and testing 
New patients visiting the University of 
Pennsylvania’s breast and ovarian 
cancer risk evaluation programme. 
108 
Hopwood 1998
38 
United Kingdom Breast Genetic counselling 
Women with 2 fold or greater risk than 
the population referred to the family 
history clinic for the first time by their 
GP or hospital clinician  
158 
Hopwood 2003
33 
United Kingdom Breast Genetic counselling 
Women with calculated lifetime breast 
cancer risk to age 80years of 1 in 6, 
attending the Family History Clinic  in 
South Manchester  
158 
Hopwood 2004
50 
United Kingdom 
Familial cancers: 
breast 75%, bowel 
17%, ovary 9% 
and other 2%. 
Genetic counselling 
Individuals attending cancer genetic risk 
counselling for the first time. 
162 
Kelly 2005
49 
United States Breast  
Genetic counselling + testing + face to face meeting 
for test result disclosure. 
Women of Ashkenazi Jewish descent 
with a family history or personal history 
of breast cancer. 
99 
Kelly 2008
48 
United States Ovarian 
Genetic counselling + testing + face to face meeting 
for test result disclosure. 
Women of Ashkenazi Jewish descent 
with a family history or personal history 
of ovarian cancer. 
78 
Kent 2000
47 
United Kingdom Breast  Genetic counselling 
Asymptomatic women referred by their 
GP to the Northern General Hospital 
Breast Cancer Family History Clinic 
Sheffield. 
69 
Landsbergen 2010
46 
The Netherlands Breast  Educational support group Women with a BRCA mutation. 34 
Liden 2003
32 
Sweden 
Breast, ovarian,   
colorectal 
Genetic counselling 
Individuals referred by their GP or 
oncologist who are attending genetic 
counselling at the oncogenetic 
outpatient clinic at the University 
hospital, Uppsala. 
77 
27 
 
Lobb 2004
31 
Australia Breast Breast cancer genetics consultation 
Women from families at high risk breast 
cancer attending their first consultation 
at a familial cancer clinic within 
Australia before genetic testing. 
 
158 
Maheu 2010
30 
Canada Pancreatic 
Pancreatic cancer counselling and screening 
programme 
Individuals with a family history of 
pancreatic cancer participating in 
counselling and individuals with a 
BRCA2 mutation participating in a 
screening programme. 
198 
Meiser 2001
45 
Australia Breast  Genetic counselling 
Women with a family history of breast 
cancer who approached familial cancer 
clinics in five Australian states between 
November 1996 and January 1999. 
218 
Mertens 2008
44 
United States Breast  Oncologist-based counselling 
Patients referred for assessment of 
breast cancer risk at a high risk clinic of 
a comprehensive breast cancer. 
81 
Mikkelsen 2007
43 
Denmark Breast  Genetic counselling 
Women at risk of breast cancer referred 
for genetic counselling by their 
physician. 
213 
Nordin 2002
36 
Sweden 
Breast, ovarian, 
colorectal 
Genetic counselling 
Subjects referred for genetic counselling 
regarding risk of breast, ovarian or 
colorectal cancer at the oncogenetic 
outpatient clinic at Uppsala University 
Hospital. 
63 
Rantala 2009
29 
Sweden 
Breast, ovarian, 
colorectal, 
endometrial, 
gastric 
Genetic counselling 
Patients referred to oncogenetic 
counselling for breast, ovarian, 
colorectal, endometrial, gastric cancer at 
the Karolinska University Hospital. 
215 
Sagi 1998
42 
Israel Breast Genetic counselling 
Women attending a genetic clinic 
because they have a family history of 
breast cancer. 
60 
Warner 2003
41 
Canada Breast 
Breast cancer information aid (booklet and 
audiotape) 
Women with a family history of breast 
cancer. 
203 
28 
 
Watson
37 
United Kingdom Breast Genetic counselling 
Women with a family history of breast 
cancer attending a cancer genetics clinic 
for counselling. 
268 
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Figure 1 legend: Forest plot of the effect of educational interventions on mean perceived risk 
in RCTs in the short and long term. We stratified according to the length of follow-up, defined as short term 
(<=3 months) or long term (>3 months). Effectiveness was defined by the standardised mean difference between 
treatment group means, standardised by the standard deviation at follow-up pooled across treatment groups. A positive 
difference indicates increased mean risk perception in the intervention group relative to the comparison group. 
Perceived risk could increase or decrease but the measure of effect is whether the education intervention changed risk 
perception. Standardized differences are pooled using random effects chosen because of differences between the trials 
in interventions and scales.  
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Figure 2 legend: Forest plot of the effect of educational interventions on perceived risk in 
observational studies in the short and long term. We stratified according to the length of follow-up, 
defined as short term (<=3 months) or long term (>3 months). Effectiveness was defined by the standardised mean 
difference, between baseline and post-clinic means, standardized by the standard deviation at follow-up pooled across 
groups. A positive difference indicates an increased mean perceived risk post-intervention relative to baseline. Due to 
heterogeneous study designs, pooled effects are not presented.  
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Figure 3 legend: Forest plot of the effect of educational interventions in RCTs on risk 
accuracy in the short and long term. We stratified according to the length of follow-up, defined as short term 
(<=3 months) or long term (>3 months). Effectiveness was defined by the difference in risk accuracy (%), between 
groups. An odds ratio of greater than 1 indicated increased accuracy in risk perception. Standardized differences were 
pooled using random effects.  
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Figure 4: Forest plot of the effect of educational interventions on risk accuracy in 
observational studies in the short and long term. Results are stratified according to the length of follow-
up, defined as short term <=3 months or long term >3 months. Effectiveness is defined by the difference between 
baseline and post-intervention risk accuracy (%). An odds ratio of greater than 1 indicates increased accuracy in risk 
perception. Due to heterogeneous study designs, we did not present the pooled effects. 
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Supplementary table 1: Search strategy in Medline   
Question components and relevant search terms  Type of terms 
Free text  MeSH 
The population: People affected by cancer or at moderate/ high risk of cancer 
1. exp. Neoplasms 
2. Neoplasm*.tw.      
3. cancer*.tw.      
4. tumo?r*.tw.                                 
5. ((neoplasm*ORcancer*OR tumo?r*)adj3(relapse* OR recurrence*)).tw. 
6. or/1-5 
 
 
X 
X 
X 
X 
  
                 X 
 
 
 
 
 
Interventions: Educational interventions  
7. education/ 
8. counselling/ 
9. exp. patient education/ 
10. patient education handout/ 
11. (health adj3 education).tw 
12. ((education*)adj3(intervention* OR  programme?e* OR tool* OR 
strateg*)).tw. 
13. ((patient*)adj3(information* OR  instruction* OR training OR toolkit OR 
website OR handout )).tw. 
14. or/7-13 
 
 
 
 
 
X 
X 
X 
  
                X 
X 
X 
X 
 
Outcomes: risk perception, risk knowledge 
15. exp risk/ 
16. ((risk*) adj3(understanding OR perception OR communication OR 
counsel?ing OR presentation OR recall OR accuracy OR knowledge OR 
education)).tw. 
17. ((perceived OR subjective) adj3 (risk*)).tw. 
18. or/15-7 
19. and/6,14,18 
 
 
X 
 
X 
 
 
  
X 
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1 I= Intervention group, C=Control group 
2An overall rate was provided for all participants, we assumed the rates were the same in the intervention and control groups 
3 Perception of risk of developing bowel cancer compared to the general population 
4 Perception of risk of developing breast cancer compared to the general population 
5 Perceived risk of bowel cancer higher than the general population 
6 Objective risk of breast cancer higher than the general population 
7 NS= not statistically significant 
8 Two P values were provided: for moderate risk group (p=0.001) and high risk group (p=0.003). 
 
 
 
 
 
 
 
 
Supplementary table 2: Effect of educational interventions on risk ratings  
Reference Outcome Time points Participants % perceived 
their risk to be 
moderate or 
high 
% objective 
risk  
moderate or 
high 
P-value 
Group1 Sample  
Randomised controlled trials  
Aneja 201227 Perceived risk of 
melanoma 
Baseline I 112 67.5 93.8  
C 98 Not reported 93.8  
3 month I 71 77 93.8 Not reported 
C 61 Not reported 93.8  
Fry 200322 Perceived risk of breast 
cancer 
Baseline I 188 96 55  
C 185 97 72  
4 week I 129 92 59 0.011 
C 147 92 77  
6 month I 123 91 59 NS7 
C 140 92 78  
Glazebrook 
200628 
Perceived risk of 
melanoma 
Baseline I 259 21.42 Not reported  
C 330 21.42 Not reported  
6 month I 214 No change Not reported NS7 
C 245 No change Not reported  
Observational studies  
Collins 
200051 
Perceived risk of bowel 
cancer3 
Baseline  157 915 796  
3 week  126 825 796 Not reported 
Kelly 
200549 
Perceived risk of breast 
cancer4 
Baseline   78.56 Not reported  
1-3 month   67.46 Not reported Not reported 
Warner 
200341 
Lifetime perceived risk of 
breast cancer 
Baseline  160 94 61  
After 
reviewing 
the aid 
 160 62 61 <=0.0038 
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Supplementary table 3: Predictors of change in risk perception 
Reference Dependant variable Predictors variables βeta P-value Odds Ratio 
 (95% CI) 
Randomised Controlled Trials 
Bowen 200420 Change in perceived risk Lifetime Gail1 risk score 0.67 0.02  
  Baseline perceived risk 0.5 0.001  
  Baseline anxiety symptoms 5.4 0.04  
  Genetic counselling arm 6.1 0.001  
  Genetic/psychosocial arm 8.0 0.001  
      
Lerman 199517 Improvement in risk 
comprehension 
Treatment group 1.25 0.01 3.49 (1.28; 9.48) 
  Baseline breast cancer 
preoccupation 
-0.14 0.02 0.87 (0.77; -0.98) 
  White women -1.09 0.05 0.34 (0.11; -0.99) 
 
Observational studies 
Codori 200552 Change in perceived risk Higher baseline risk 
perception 
-0.4 P<0.0001  
  Older age -0.4 0.006  
  Higher estimated objective 
risk 
-0.3 0.04  
      
Gurmankin 
200534 
Accuracy of breast 
cancer risk perception 
Pre-counselling worry 7.31 0.01  
  Higher education 34.15 0.05  
      
Kelly 200848 Change in subjective risk 
of ovarian cancer  
Survival time  0.009  
  Older age  0.001  
      
Lobb 200431 Accuracy of breast 
cancer risk perception 
Receiving a written summary 
of the genetic counselling 
session 
 0.02 2.61 (1.14; 6.02) 
      
Maheu 201030 Level of risk perception Baseline levels of risk 
perception 
 P<0.001  
      
Mikkelsen 200743 Inaccurate risk Risk communicated in words   5.50 (1.88; 16.10)  
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perception  only 
  Inaccurate risk perception at 
baseline 
  5.07 (2.07; 15.79) 
  Presence of a familial 
mutation 
  4.38 (1.32; 14.48) 
  Having one or more daughters   2.68 (1.02; 7.05) 
      
Mertens 200844 Patient-perceived 5-year 
risk 
Pre-counselling patient-
perceived risk 
 P<0.0001  
  Counselling oncologist  0.003  
                
 
1
 The Gail model is a validated risk-assessment tool based on personal and family characteristics
37 
 
Supplementary figure 1: Study flow chart 
 
 
38 
 
 
Supplementary figure 2 legend: Summary of risk of bias (%) for all included randomised 
controlled trials 
 
 
 
Supplementary figure 3 legend: Summary of risk of bias (%) for all included prospective 
observational studies 
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